US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.220
  • +0.060+1.90%
Trading Nov 21 14:33 ET
271.96MMarket Cap-1555P/E (TTM)

About Atea Pharmaceuticals Company

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Company Profile

SymbolAVIR
Company NameAtea Pharmaceuticals
Listing DateOct 30, 2020
Issue Price24.00
Founded2012
CEODr. Jean-Pierre Sommadossi,PhD
MarketNASDAQ
Employees75
Fiscal Year Ends12-31
Address225 Franklin Street,Suite 2100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-857-284-8891
Websitehttp://www.ateapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jean-Pierre Sommadossi,PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 5.93M
  • Andrea J. Corcoran
  • Chief Financial Officer, Executive Vice President, Legal and Secretary
  • 1.96M
  • Dr. Maria Arantxa Horga, M.D.
  • Chief Medical Officer
  • 1.85M
  • Dr. Janet Hammond, M.D.,PhD
  • Chief Development Officer
  • 2.11M
  • Wayne Foster
  • Executive Vice President, Finance and Chief Accounting Officer
  • 1.52M
  • John Vavricka
  • Chief Commercial Officer
  • --
  • Franklin M. Berger, C.F.A.
  • Lead Independent Director
  • 357.10K
  • Bruno Lucidi
  • Independent Director
  • 324.60K
  • Barbara G. Duncan
  • Independent Director
  • 332.10K
  • Jerome M. Ada M.D.
  • Independent Director
  • 442.10K
  • Dr. Polly A. Murphy, D.V.M.,PhD
  • Independent Director
  • 327.10K
  • Dr. Bruce Polsky, M.D.
  • Independent Director
  • 324.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data